NPC(SH:600713) Zheng Quan Zhi Xing·2025-05-19 08:22Group 1 - The announcement pertains to the exercise of investor put options and the issuer's adjustment of the coupon rate for the 2023 first phase medium-term notes issued by Nanjing Pharmaceutical Co., Ltd [1][2] - The bond has an issuance amount of 1 billion yuan, with a coupon rate of 3.10% and a maturity period of 2+1 years, starting from June 20, 2023 [2] - The investor put option can be exercised from May 22, 2025, to May 28, 2025, with a repurchase price of 100 yuan per 100 yuan face value, and the exercise date is June 20, 2025 [2] Group 2 - The issuer has the option to adjust the coupon rate, which is currently set at 3.10%, and can be reduced by 150 basis points to a new rate of 1.60%, effective from June 20, 2025 [2] - The main underwriters for the bond issuance are Bank of Communications Co., Ltd. and Industrial Bank Co., Ltd. [2] - The announcement includes contact information for the issuer and the management institution, ensuring transparency and accessibility for investors [2][3]